Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
Current Drug Therapy

Troglitazone: a new antihyperglycemic agent

Rex A. Speerhas, RPH and S. Sethu K. Reddy, MD, FRCPC
Cleveland Clinic Journal of Medicine May 1997, 64 (5) 238-240;
Donald G. Vidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rex A. Speerhas
Mr. Speerhas is a board-certified nutrition support pharmacist and a certified diabetes educator at the Cleveland Clinic.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Sethu K. Reddy
Dr. Reddy is a member of the staff of the Department of Endocrinology at the Cleveland Clinic and has research interests in the epidemiology of diabetes, its risk factors, and the implementation of guidelines.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 5 238-240
PubMed 
9149473

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online May 1, 1997.

Copyright & Usage 
Copyright © 1997 The Cleveland Clinic Foundation. All Rights Reserved.

Other Contributors 
  • Donald G. Vidt [MD]

Cited By...

  • 6 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 64 (5)
Cleveland Clinic Journal of Medicine
Vol. 64, Issue 5
1 May 1997
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Troglitazone: a new antihyperglycemic agent
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Troglitazone: a new antihyperglycemic agent
Rex A. Speerhas, S. Sethu K. Reddy
Cleveland Clinic Journal of Medicine May 1997, 64 (5) 238-240;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Troglitazone: a new antihyperglycemic agent
Rex A. Speerhas, S. Sethu K. Reddy
Cleveland Clinic Journal of Medicine May 1997, 64 (5) 238-240;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Update on current contraceptive options: A case-based discussion of efficacy, eligibility, and use
  • Antiobesity drug therapy: An individualized and comprehensive approach
  • The role of SGLT-2 inhibitors in managing type 2 diabetes
Show more Current Drug Therapy

Similar Articles

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire